Back
Solitario Resources Vs. Cidara Therapeutics Industry Stock Comparison
Sell
37
XPL
Solitario Resources
Last Price:
$0.62
Seasonality Move:
-4.47%
Buy
81
CDTX
Cidara Therapeutics
Last Price:
$50.49
Seasonality Move:
0.55%
Sell
37
Solitario Resources (XPL)
is a Sell
Is Solitario Resources a Buy, Sell or Hold?
-
The current Solitario Resources [XPL] share price is $0.64. The Score for XPL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
XPL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $48.30. The Score for CDTX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
XPL Stock Price Chart
What is Solitario Resources's stock price today?
-
The Solitario Resources share price today is $0.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XPL is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $48.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
XPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 48.56 | Sell |
Chaikin Money Flow: | -13364 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.03 | Buy |
Relative Strength Index (14 RSI): | 76.46 | Buy |
Chaikin Money Flow: | 652572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
XPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.65 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.64 | Buy |
200-day SMA: | 0.65 | Sell |
8-day EMA: | 0.65 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 0.65 | Sell |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.69 | Sell |
20-day SMA: | 35.9 | Buy |
50-day SMA: | 27.68 | Buy |
200-day SMA: | 20.84 | Buy |
8-day EMA: | 46.33 | Buy |
20-day EMA: | 39.02 | Buy |
50-day EMA: | 30.96 | Buy |
200-day EMA: | 22.55 | Buy |
Solitario Resources Earnings Growth & XPL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.03 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.70 per share, and a decrease next year of $0.58 per share.
Solitario Resources Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |